Pharmaceutical company Jaguar Health announced the promotion of Carol Lizak to the role of chief accounting officer. Lizak formerly served as Jaguar’s vice president of finance and corporate controller.

Lizak has 20-plus years of corporate controllership and financial planning and analysis experience under U.S. GAAP & IFRS. Prior to joining Jaguar, she served as senior director and corporate controller of Zosano Pharma Corporation; as controller of Quantum Secure; and as executive director, corporate controller of Alexza Pharmaceuticals.

Previously, she spent nine years as corporate controller of a subsidiary of HID Global Corporation.

Topics